While big pharma has traditionally looked for new ways to control large budgets and speed up process across R&D and commercial divisions, Roche took a radical approach in its commercial divisions three years ago. They went a different way and say the rewards for employees and the business have been significant. In Vivo covers how at a 16 September talk at Roche Pharma Day for investors, Bill Anderson, CEO of Roche’s Pharma Division, said, “On the commercial front, we’ve eliminated budgets in most of the world. And basically, we’ve replaced that with an understanding fo what people are to deliver.” See how productivity and other metrics are up.